Market Cap | ₹1,554Cr |
ROE | 15.07% |
P/E Ratio(TTM) | 46.69 |
EPS(TTM) | 6.39 |
P/B Ratio | 7.36 |
Dividend Yield | 0.00% |
Industry P/E | 66.49 |
Book Value | 40.56 |
Debt to Equity | 0.42 |
Face Value | 2 |
Parent Organisation | Suraksha Diagnostic |
NSE Symbol | SURAKSHA |
FUND NAME | AUM(%) |
---|---|
Nippon India Pharma Fund Direct Growth | 1.34% |
JM Value Fund Direct Plan Growth | 0.68% |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Dr Lal PathLabs | NA (0.00%) | 54.07 | ||
Metropolis Healthcare | NA (0.00%) | 74.67 | ||
Vijaya Diagnostic Centre | NA (0.00%) | 68.94 | ||
Thyrocare Technologies | NA (0.00%) | 62.99 |